Cullinan Oncology Ownership | Who Owns Cullinan Oncology?

Cullinan Oncology Ownership Summary

Cullinan Oncology is owned by 33.66% institutional investors, 4.47% insiders, and 61.87% retail investors. Bioimpact capital is the largest institutional shareholder, holding 13.11% of CGEM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.87% of its assets in Cullinan Oncology shares.

CGEM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cullinan Oncology	33.66%	4.47%	61.87%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bioimpact capital	7.65M	13.11%	$93.16M
Bvf inc/il	5.75M	9.86%	$70.04M
Blackrock	3.55M	8.25%	$61.92M
Blackrock funding, inc. /de	4.37M	7.49%	$53.24M
Deerfield management company, l.p. (series c)	3.38M	5.79%	$41.16M
Vanguard group	2.94M	5.03%	$35.76M
Blue owl capital lp	2.37M	4.06%	$28.88M
Franklin resources	2.20M	3.77%	$26.79M
State street	2.12M	3.64%	$25.88M
Alliancebernstein	2.01M	3.45%	$24.50M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bioimpact capital	7.65M	13.23%	$93.16M
Foresite capital management v	657.90K	6.67%	$8.01M
Blue owl capital lp	2.37M	6.65%	$28.88M
Lynx1 capital management lp	1.26M	5.74%	$15.32M
Patient square capital lp	878.90K	4.00%	$10.70M
Foresite capital management vi	634.56K	3.44%	$7.73M
Bvf inc/il	5.75M	2.37%	$70.04M
Nextech invest	1.14M	2.25%	$13.90M
Vr adviser	1.38M	1.15%	$16.81M
Twin focus capital partners	595.49K	1.07%	$7.25M

Top Buyers

Holder	Shares	% Assets	Change
Kynam capital management, lp	1.25M	0.90%	1.25M
Blackrock	3.55M	0.00%	1.12M
Artal group	1.06M	0.47%	1.06M
Orbimed advisors	1.94M	0.49%	872.50K
Lynx1 capital management lp	1.26M	5.74%	846.97K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-2.32M
Holocene advisors, lp	-	-	-1.53M
Cormorant asset management, lp	-	-	-1.13M
Perceptive advisors	-	-	-749.92K
Logos global management lp	-	-	-700.00K

New Positions

Holder	Shares	% Assets	Change	Value
Kynam capital management, lp	1.25M	0.90%	1.25M	$15.26M
Artal group	1.06M	0.47%	1.06M	$18.45M
Boxer capital	657.89K	0.60%	657.89K	$11.47M
Foresite capital management vi	634.56K	3.44%	634.56K	$7.73M
Woodline partners lp	167.31K	0.01%	167.31K	$2.04M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-5.00
Srs capital advisors	-7.00
Capital performance advisors llp	-13.00
Rothschild investment	-60.00
Bessemer group	-105.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	78	-45.07%	19,633,373	-69.80%	33	0.27%	44	-48.24%	22	-21.43%
Sep 30, 2024	142	3.65%	65,005,696	3.31%	111	0.85%	85	-14.14%	28	12.00%
Jun 30, 2024	136	18.26%	62,925,233	59.82%	146	1.73%	98	60.66%	25	-30.56%
Mar 31, 2024	115	1.77%	39,373,046	6.88%	92	1.24%	61	-11.59%	36	56.52%
Dec 31, 2023	113	6.60%	36,838,443	-3.03%	86	0.95%	69	50.00%	23	-25.81%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.68M	2.87%	-
Vanguard US Total Market Shares ETF	1.50M	2.57%	-
iShares Russell 2000 ETF	1.36M	2.33%	-11.82K
Franklin Biotechnology Discv A(acc)USD	842.14K	1.44%	-
Franklin US Small Cap Growth Equity	791.57K	1.36%	-
Franklin Small Cap Growth Adv	791.57K	1.35%	-
Vanguard Institutional Extnd Mkt Idx Tr	788.25K	1.35%	1.59K
AB Small Cap Growth A	783.43K	1.34%	-20.86K
SPDR® S&P Biotech ETF	673.12K	1.15%	-7.21K
Fidelity Small Cap Index	514.67K	0.88%	-9.64K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 25, 2025	Jones Jeffrey Alan	Chief Medical Officer	Sell	$41.75K
Feb 25, 2025	AHMED NADIM	President and CEO	Sell	$106.87K
Feb 25, 2025	Michaelson Jennifer	Chief Scientific Officer	Sell	$32.04K
Feb 25, 2025	SUMER JACQUELYN L	Chief Legal Officer	Sell	$32.04K
Jan 06, 2025	Michaelson Jennifer	Chief Scientific Officer	Sell	$50.04K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	5
2024 Q4	-	6
2024 Q3	-	2
2024 Q2	-	3
2024 Q1	-	5

CGEM Ownership FAQ

Who Owns Cullinan Oncology?

Cullinan Oncology shareholders are primarily institutional investors at 33.66%, followed by 4.47% insiders and 61.87% retail investors. The average institutional ownership in Cullinan Oncology's industry, Biotech Stocks , is 68.48%, which Cullinan Oncology falls below.

Who owns the most shares of Cullinan Oncology?

Cullinan Oncology’s largest shareholders are Bioimpact capital (7.65M shares, 13.11%), Bvf inc/il (5.75M shares, 9.86%), and Blackrock (3.55M shares, 8.25%). Together, they hold 31.22% of Cullinan Oncology’s total shares outstanding.

Does Blackrock own Cullinan Oncology?

Yes, BlackRock owns 8.25% of Cullinan Oncology, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.92M$. In the last quarter, BlackRock increased its holdings by 1.12M shares, a 46.16% change.

Who is Cullinan Oncology’s biggest shareholder by percentage of total assets invested?

Bioimpact capital is Cullinan Oncology’s biggest shareholder by percentage of total assets invested, with 13.23% of its assets in 7.65M Cullinan Oncology shares, valued at 93.16M$.

Who is the top mutual fund holder of Cullinan Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cullinan Oncology shares, with 2.87% of its total shares outstanding invested in 1.68M Cullinan Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools